Conduct Disorder Clinical Trial
Official title:
A Multiple Biomarker Approach to Investigating Psychosocial Intervention Treatment Response in Justice-Involved Youth With Conduct Disorder
Verified date | August 2021 |
Source | Centre for Addiction and Mental Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This research focuses on youth with conduct disorder (CD), and a history of violence. CD is a youth neurodevelopmental disorder that is commonly associated with criminality. Although psychosocial interventions that address impulsivity and self-control have been shown to be effective at helping promote prosocial behavior in patients with CD, the biological changes that occur as a result of treatment are not well understood. This study will explore changes in the brain function of the anterior cingulate cortex (ACC) in response to a common psychosocial intervention (Stop, Now and Plan). This study will contribute to our understanding of biological mechanisms involved in therapeutic gains among children with behavioural problems and youth offenders; therefore, it will inform further development of treatment programs for children/youth with impulsive behaviours.
Status | Completed |
Enrollment | 27 |
Est. completion date | August 11, 2021 |
Est. primary completion date | February 5, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 6 Years to 11 Years |
Eligibility | Inclusion Criteria (SNAP Treatment Group): - Historical diagnosis of CD as per the K-SADS, which will be corroborated by DSM-5 criteria obtained by clinical assessment, and a CBCL, externalizing sub-score of 70 and above. Inclusion Criteria (SNAP Control Group) - No history of psychiatric illness as assessed by the Kiddi - Schedule for Affective Disorders and Schizophrenia Present and Lifetime version (K-SADS) - No history of criminal justice system involvement. Exclusion Criteria (ALL Groups): - Serious, unstable medical condition that precludes safe participation in the study - History of neurological or endocrine disorder - Any contraindication to safe MRI scanning, including claustrophobia - Psychotic or bipolar disorder - Current drug use measured by urinalysis - Full-scale IQ of 80 or lower (cut-off for borderline intellectual functioning) measured using the Wechsler Abbreviated Scales of Intelligence - 2nd Edition (WASI-II) |
Country | Name | City | State |
---|---|---|---|
Canada | Centre for Addiction and Mental Health | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
Centre for Addiction and Mental Health | Ontario Mental Health Foundation |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline: blood-oxygen-level dependent (BOLD) activation of anterior cingulate cortex as measured by functional magnetic resonance imaging | Difference in ACC BOLD activation to commission errors (contrast of BOLD response during commission errors vs. BOLD response during correct hits) will be tested using a 2 (Session: pre-SNAP vs. post-SNAP) × 2 (Group: treatment responders vs. non-treatment responders) within subject, mixed model analysis of covariance (ANCOVA), controlling for the effect of age, to investigate the two-way interaction between session and group. (Note: Commission errors compose a measure produced by the Go/No-Go task.) | Measured before and after the 13-week program |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03535805 -
Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances
|
N/A | |
Recruiting |
NCT05449002 -
Digital Single Session Intervention for Youth Mental Health
|
N/A | |
Withdrawn |
NCT02247986 -
Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
|
Phase 1/Phase 2 | |
Recruiting |
NCT04631042 -
Developing Brain, Impulsivity and Compulsivity
|
||
Completed |
NCT02485587 -
Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents
|
N/A | |
Completed |
NCT00819429 -
Supplements and Social Skills Intervention Study
|
N/A | |
Completed |
NCT00626236 -
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
|
Phase 2 | |
Completed |
NCT01085305 -
The Effectiveness of Parent-Child Interaction Therapy (PCIT)
|
N/A | |
Completed |
NCT00250354 -
A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation
|
Phase 3 | |
Completed |
NCT00000385 -
Long-Term Lithium Treatment for Aggressive Conduct Disorder
|
Phase 3 | |
Withdrawn |
NCT01443949 -
Teenagers, Drug Addiction, and Reward and Impulse Control
|
||
Completed |
NCT04091633 -
School Health Implementation Network: Eastern Mediterranean
|
N/A | |
Completed |
NCT02563145 -
Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents
|
N/A | |
Completed |
NCT02766101 -
Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges
|
N/A | |
Completed |
NCT00404911 -
Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth
|
N/A | |
Completed |
NCT00051727 -
Prevention of School Dropout for Mexican American Adolescents
|
Phase 2 | |
Completed |
NCT03292848 -
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
|
Phase 1 | |
Recruiting |
NCT06373484 -
Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents
|
N/A | |
Recruiting |
NCT05637320 -
Big Feelings: A Study on Children's Emotions in Therapy
|
N/A | |
Recruiting |
NCT04170738 -
Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
|
Phase 4 |